A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...

President Joe Biden's proposal to have GLP-1 weight-loss drugs such as Wegovy, Ozempic, Zepbound and Mounjaro covered by Medicare and Medicaid would help tackle the public-health crisis of obesity, ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...

Understanding Medicare basics may be one of the most maddening tasks you'll face when heading into retirement. Figuring out when to enroll in Medicare and which parts of Medicare to elect can be ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...